Literature DB >> 14998570

Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors.

Graeme Milligan1.   

Abstract

Bioluminescence (BRET)- and fluorescence resonance energy transfer (FRET) techniques have become integral approaches in studies of protein-protein interactions in living cells. They rely on non-radiative transfer of energy between donor and acceptor species that can be appended to the proteins of interest. These techniques display exquisite dependence on distance and orientation between the energy transfer partners. This means they are well suited to measure both small conformational changes in response to ligand binding between partner proteins that remain within a complex or more extensive translocations of proteins between cellular compartments that occur in response to cellular challenge. Introduction of both energy donor and acceptor into a single polypeptide can also allow the detection of ligand-induced conformational switches in monomeric proteins in the millisecond time scale. Many of these approaches are amenable to high throughput screening and the drug discovery process. G protein-coupled receptors (GPCRs) represent a key drug target class. Specific applications of resonance energy transfer techniques to the identification of ligands for this class of protein are highlighted to illustrate general principles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998570     DOI: 10.1016/j.ejps.2003.11.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  25 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET.

Authors:  Pascale G Charest; Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2005-04       Impact factor: 8.807

Review 3.  Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells.

Authors:  Kevin D G Pfleger; Karin A Eidne
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

4.  BRET3: a red-shifted bioluminescence resonance energy transfer (BRET)-based integrated platform for imaging protein-protein interactions from single live cells and living animals.

Authors:  Abhijit De; Pritha Ray; Andreas Markus Loening; Sanjiv Sam Gambhir
Journal:  FASEB J       Date:  2009-04-07       Impact factor: 5.191

Review 5.  Cellular assays as portals to seven-transmembrane receptor-based drug discovery.

Authors:  Terry P Kenakin
Journal:  Nat Rev Drug Discov       Date:  2009-07-17       Impact factor: 84.694

Review 6.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

7.  Detecting Secretory Proteins by Acoustic Droplet Ejection in Multiplexed High-Throughput Applications.

Authors:  Michael J Iannotti; Ryan MacArthur; Richard Jones; Dingyin Tao; Ilyas Singeç; Sam Michael; James Inglese
Journal:  ACS Chem Biol       Date:  2019-02-14       Impact factor: 5.100

8.  Comparison of Förster-resonance-energy-transfer acceptors for tryptophan and tyrosine residues in native proteins as donors.

Authors:  Yi zhang; Xiaolan Yang; Lin Liu; Xuexia Huang; Zuexia Huang; Jun Pu; Gaobo Long; Ling Zhang; Dong Liu; Bangtian Xu; Juan Liao; Fei Liao
Journal:  J Fluoresc       Date:  2012-09-22       Impact factor: 2.217

9.  Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops.

Authors:  Anand Ponnuswamy; Ted Hupp; Robin Fåhraeus
Journal:  Genes Cancer       Date:  2012-03

Review 10.  Developments in preclinical cancer imaging: innovating the discovery of therapeutics.

Authors:  James R W Conway; Neil O Carragher; Paul Timpson
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.